A gene of interest is simply any gene that a researcher has chosen to study, manipulate, or use for a specific purpose. It’s not a special category of gene. Every gene in every organism could be a “gene of interest” depending on the research question. The term shows up constantly in genetics and biotechnology because scientists need a way to distinguish the one gene they’re focused on from the roughly 20,000 other genes in a human genome (or the thousands in simpler organisms).
The concept matters because modern genetics often involves pulling a single gene out of an organism’s DNA, making copies of it, inserting it into another organism, or editing it directly. The gene of interest is the target of all that work.
How Researchers Choose a Gene of Interest
Scientists pick a gene of interest based on what they’re trying to learn or accomplish. There are two broad approaches. In the classical method, researchers start with something observable, like fruit flies with white eyes or curly wings, and work backward to find which gene is responsible for that trait. The goal is to connect an organism’s appearance or behavior to a specific stretch of DNA.
The modern approach often works in the opposite direction. A researcher starts with a gene sequence (sometimes discovered through genome sequencing) and then deliberately mutates or disables it to see what happens. This “sequence to function” strategy helps reveal what a gene actually does in a living organism.
When the goal is medical, researchers use a “guilt by association” strategy. The most promising gene candidates are the ones that resemble genes already linked to the disease being studied. For example, when investigating type 2 diabetes, a gene involved in potassium channel activity became a strong candidate because potassium channels play a known role in diabetes, and the gene’s protein interacts with another protein already established as a key player in diabetes and obesity. Computational tools now help scientists sift through thousands of candidates by comparing gene function, protein interactions, and known disease associations to prioritize which genes are worth investigating.
Isolating a Gene From the Genome
Once researchers know which gene they want, they need to physically separate it from the rest of the organism’s DNA. Two core techniques make this possible.
The first uses restriction enzymes, proteins originally found in bacteria that cut DNA at very specific sequences. Different restriction enzymes recognize different sequences, so it’s relatively straightforward to find one that will snip out a fragment containing the target gene. This produces DNA pieces of precise, predictable sizes.
The second technique is PCR (polymerase chain reaction), which acts like a molecular photocopier. Researchers design two short pieces of synthetic DNA that match the sequences flanking their gene of interest. These act as bookends, telling the copying machinery exactly where to start and stop. The DNA is heated to separate its two strands, the synthetic bookends attach, and a special enzyme builds new copies of everything between them. Each cycle doubles the amount of DNA, so after 20 to 30 cycles, a single copy of the gene has been amplified roughly a billionfold. PCR can accomplish in a few hours what older cloning methods took days to do.
Inserting the Gene Into a Vector
An isolated gene on its own can’t do much. To study it, produce its protein, or deliver it into another organism, researchers need to place it inside a carrier called a vector. The most common vectors are plasmids: small, circular loops of DNA found naturally in bacteria.
The process works like a cut-and-paste operation. The plasmid is cut open with the same restriction enzyme used to isolate the gene, creating matching sticky ends on both pieces of DNA. The gene fragment and the opened plasmid are mixed together, and the sticky ends naturally pair up. An enzyme called DNA ligase then seals the gene into the plasmid, forming a new circular molecule called recombinant DNA.
This recombinant plasmid is then introduced into bacterial cells that have been made temporarily permeable to DNA. As the bacteria multiply, they copy the plasmid along with their own DNA, producing enormous quantities of the gene of interest and (if the vector is designed for it) the protein that gene encodes. Newer methods skip restriction enzymes entirely and use PCR-based approaches where overlapping DNA sequences recombine naturally inside the bacteria, streamlining the whole process.
Confirming the Right Gene Was Captured
After cloning, researchers need to verify they’ve actually captured the correct gene and not some random fragment. When building a DNA library (a collection of bacteria, each carrying a different fragment of the original genome), only a tiny fraction of the colonies will contain the gene of interest. Scientists screen the library using DNA probes, short synthetic sequences that are complementary to part of the target gene. These probes are labeled so they produce a detectable signal when they bind to matching DNA, identifying which bacterial colonies carry the right fragment.
PCR also serves as a confirmation tool. By designing primers specific to the gene of interest and running a PCR reaction on DNA extracted from the cloned bacteria, researchers can quickly check whether the expected fragment is present and the right size.
Reporter Genes: Tracking the Gene of Interest
Sometimes researchers don’t just want to clone a gene; they want to watch it in action inside a living cell. This is where reporter genes come in. A reporter gene encodes a protein that’s easy to detect against the background of all the cell’s other proteins. The most famous example is GFP (green fluorescent protein), which glows green under ultraviolet light.
Researchers attach a reporter gene to the regulatory region of their gene of interest. When the gene of interest would normally turn on, the reporter turns on instead (or alongside it), producing a visible signal. This lets scientists track when, where, and how strongly a gene is active without needing to measure the gene’s own protein directly. The reporter gene is a tool; the gene of interest is the subject being studied.
Real-World Applications
The concept of a gene of interest isn’t just academic. It’s the foundation of some of the most consequential advances in medicine and agriculture.
One of the earliest and most famous examples: in 1982, researchers used recombinant DNA technology to insert the human insulin gene into E. coli bacteria, producing the first commercially available synthetic human insulin (Humulin). The human insulin gene was the gene of interest, and the bacterial cells served as tiny protein factories.
Gene therapy takes this further by targeting genes responsible for disease. More than a dozen FDA-approved gene therapies now exist, each built around a specific gene of interest. Zolgensma delivers a functional copy of the gene responsible for spinal muscular atrophy directly into a patient’s cells. Luxturna does the same for a gene that causes inherited retinal disease and vision loss. For sickle cell disease, Casgevy uses CRISPR gene-editing technology to reactivate dormant hemoglobin genes that can compensate for the defective ones, making it the first approved CRISPR-based therapy.
Clinical trials are pushing into new territory. Companies are testing CRISPR-based edits to specific genes in liver cells to treat conditions like hereditary high cholesterol, amyloidosis (a protein buildup disease), and hereditary angioedema. In each case, the entire therapy is designed around modifying one carefully chosen gene of interest.
Why the Term Keeps Showing Up
If you’re reading a genetics textbook, a research paper, or a biotech company’s description of its work, “gene of interest” appears constantly because it’s a universal placeholder. It doesn’t refer to one specific gene. It refers to whichever gene is the focus of the work at hand. For a diabetes researcher, it might be a gene involved in insulin signaling. For an agricultural scientist, it could be a gene that confers drought resistance in crops. For a cancer biologist, it might be a gene that drives tumor growth.
The term exists because the techniques for isolating, copying, inserting, and editing genes are largely the same regardless of which gene you’re working with. What changes is the target. The gene of interest is that target.